Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2022-12-21 2022-12-20
Drug Identification Number 02242810 02242810
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
ATC code N05CM N05CM
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-12-19 2022-12-19
Actual start date
Estimated end date 2023-01-06
Actual end date 2022-12-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments